HB 1318 - AS AMENDED BY THE HOUSE
7Mar2024... 0424h
2024 SESSION
24-2378
05/08
HOUSE BILL 1318
AN ACT relative to the duties of the opioid abatement advisory commission.
SPONSORS: Rep. Nagel, Belk. 6; Rep. Roy, Rock. 31; Rep. Lundgren, Rock. 16
COMMITTEE: Health, Human Services and Elderly Affairs
-----------------------------------------------------------------
ANALYSIS
This bill defines integrated pain management and adds duties to the New Hampshire opioid abatement advisory commission involving support for pain management services.
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
Explanation: Matter added to current law appears in bold italics.
Matter removed from current law appears [in brackets and struckthrough.]
Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.
7Mar2024... 0424h 24-2378
05/08
STATE OF NEW HAMPSHIRE
In the Year of Our Lord Two Thousand Twenty Four
AN ACT relative to the duties of the opioid abatement advisory commission.
Be it Enacted by the Senate and House of Representatives in General Court convened:
1 New Paragraph; Controlled Drug Prescription Health and Safety Program. Amend RSA 126-A:89 by inserting after paragraph VI the following new paragraph:
VI-a. "Integrative pain management" means the systematic combination of a variety of allopathic and non-allopathic services that address the biological, psychological, social, and spiritual needs of the patient. It is person-centered and focuses on maximizing function and wellness. Care plans are developed through a shared decision-making model that reflects the available evidence regarding optimal clinical practice and the person’s goals and values.
2 Opioid Abatement Advisory Commission; Duties. Amend RSA 126-A:86, I(b)(16) and (17) to read as follows:
(16) Support for public and non-public school programs and services for students with OUD and any co-occurring SUD/MH issues or who have been affected by OUD and any co-occurring SUD/MH issues within their family; [and]
(17) Support secondary and tertiary prevention through harm reduction programs[.];
(18) Support medication assisted treatment (MAT) type services which support the pharmaceutical and non-pharmaceutical needs of patients with chronic pain, and/or those with pain who are in hospice and/or palliative care who have responded well to opioid therapy as defined in RSA 318-B:41, II(d)(7), yet have been subject to non-consensual dose reduction, detoxification, and/or abandonment by their providers; and
(19) Support services which increase access to comprehensive, integrative pain management services as an alternative to opioid therapy for those with acute and/or chronic pain and/or those with pain who are in hospice and/or palliative care.
3 Effective Date. This act shall take effect 60 days after its passage.
| Date | Amendment |
|---|---|
| Feb. 23, 2024 | 2024-0424h |
| Date | Body | Type |
|---|---|---|
| Jan. 10, 2024 | House | Hearing |
| Jan. 10, 2024 | House | Exec Session |
| Feb. 21, 2024 | House | Exec Session |
| Feb. 21, 2024 | House | Floor Vote |
| March 27, 2024 | Senate | Hearing |
March 20, 2024: Hearing: 03/27/2024, Room 101, LOB, 09:40 am; SC 12
March 13, 2024: Introduced 03/07/2024 and Referred to Health and Human Services; SJ 7
March 7, 2024: Ought to Pass with Amendment 2024-0424h: MA VV 03/07/2024 HJ 7
March 7, 2024: Amendment # 2024-0424h: AA VV 03/07/2024 HJ 7
Feb. 23, 2024: Committee Report: Ought to Pass with Amendment # 2024-0424h 02/21/2024 (Vote 19-0; CC) HC 9 P. 9
Feb. 15, 2024: Executive Session: 02/21/2024 11:00 am LOB 203
Jan. 5, 2024: Executive Session: 01/10/2024 11:30 am LOB 210-211
Jan. 5, 2024: Public Hearing: 01/10/2024 10:15 am LOB 210-211
Dec. 6, 2023: Introduced 01/03/2024 and referred to Health, Human Services and Elderly Affairs HJ 1